The PE Ratio as of November 2024 (TTM) for Organicell Regenerative Medicine, Inc. (OCEL) is -1.57

According to Organicell Regenerative Medicine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.57. This represents a change of -40.81% compared to the average of -2.65 of the last 4 quarters.

Organicell Regenerative Medicine, Inc. (OCEL) Historical PE Ratio (quarterly & annually)

How has OCEL PE Ratio performed in the past?

The mean historical PE Ratio of Organicell Regenerative Medicine, Inc. over the last ten years is -25.06. The current -1.57 PE Ratio has changed 525.43% with respect to the historical average. Over the past ten years (40 quarters), OCEL's PE Ratio was at its highest in in the April 2017 quarter at -0.10. The PE Ratio was at its lowest in in the October 2014 quarter at -12443.47.

Organicell Regenerative Medicine, Inc. (OCEL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Organicell Regenerative Medicine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Organicell Regenerative Medicine, Inc. (OCEL) Average PE Ratio

How has OCEL PE Ratio performed in the past?

The current PE Ratio of Organicell Regenerative Medicine, Inc. (OCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Organicell Regenerative Medicine, Inc. (OCEL) PE Ratio vs. Peers

How is OCEL’s PE Ratio compared to its peers?

Organicell Regenerative Medicine, Inc.’s PE Ratio is greater than Cellectis S.A. (-2.83), greater than Biotron Limited (-4.85), greater than Awakn Life Sciences Corp. (-1.69), less than TC Biopharm (Holdings) Plc (-0.02), less than Bioasis Technologies Inc. (0), less than BetterLife Pharma Inc. (0), greater than Covalon Technologies Ltd. (-2.56), greater than Protara Therapeutics, Inc. (-102.04), less than Vaccinex, Inc. (-1.35), less than Monopar Therapeutics Inc. (-0.33), greater than Miromatrix Medical Inc. (-8.34), greater than Surrozen, Inc. (-3.41), less than null (-0.70),

Build a custom stock screener for Organicell Regenerative Medicine, Inc. (OCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organicell Regenerative Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organicell Regenerative Medicine, Inc. (OCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organicell Regenerative Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.